Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pretax income is the income that a company earns before paying income taxes. Actavia Life Sciences's pretax income for the
three
months ended in Mar. 2024 was $-0.10 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.41 Mil.
Actavia Life Sciences's pretax margin was %.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Actavia Life Sciences Pre-Tax Income Related Terms
Actavia Life Sciences Pre-Tax Income Historical Data
* Premium members only.
The historical data trend for Actavia Life Sciences's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RASP vs BWV, FNCH, CWBR: Pre-Tax Income Comparison
For the Biotechnology subindustry, Actavia Life Sciences's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Actavia Life Sciences Pre-Tax Income vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Actavia Life Sciences's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Actavia Life Sciences's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.41 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Actavia Life Sciences (RASP) has a Pre-Tax Income of $-0.41 Mil as of Mar. 2024. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Actavia Life Sciences and its competitors.
Is Actavia Life Sciences' Pre-Tax Income too high?
Actavia Life Sciences' current Pre-Tax Income is $-0.41 Mil.
How does Actavia Life Sciences' Pre-Tax Income compare to BWV and FNCH?
Actavia Life Sciences' Pre-Tax Income of $-0.41 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pre-Tax Income for a Biotechnology company?
A good Pre-Tax Income depends on the Biotechnology industry context. However, Pre-Tax Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pre-Tax Income mean?
A high Pre-Tax Income can signal that a stock is expensive relative to its fundamentals. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Actavia Life Sciences and its competitors. Actavia Life Sciences's current Pre-Tax Income is $-0.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Actavia Life Sciences stock overvalued right now?
Actavia Life Sciences (RASP) has a current Pre-Tax Income of $-0.41 Mil. The current Pre-Tax Income is $-0.41 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pre-Tax Income calculated?
Pre-Tax Income is calculated from a company's financial statements. For Actavia Life Sciences (RASP), the current Pre-Tax Income is $-0.41 Mil as of Mar. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Actavia Life Sciences Inc is a clinical-stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, mainly focusing on the treatment of leukemia. Its primary indication is Acute Myeloid Leukemia (AML), which may be fatal within weeks to months, has about a 5-year survival rate of only about 25% and very poor prospects for the long-term survival of patients.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RASP has been successfully added to your 
